Cisplatin and doxorubicin for invasive basal cell carcinoma of the eyelids
Neudorfer, M.; Merimsky, O.; Lazar, M.; Geyer, O.
Annals of Ophthalmology 25(1): 11-13
1993
ISSN/ISBN: 0003-4886 PMID: 8427483 Document Number: 6332
Cisplatin and doxorubicin were used in the treatment of recurrent invasive basal cell carcinoma (BCC) of the medial canthus and orbit. Complete remission was observed after treatment termination, and this was still evident five years later. Systemic chemotherapy offers an alternative mode of treatment for selected cases of advanced BCC.
Document emailed within 1 workday
Related Documents
Tomas, S. 2015: Early detection and non-invasive diagnosis of basal cell carcinoma using a dermatoscope Australian Family Physician 44(9): 660-662West, R.J.; Zweig, S.F. 1997: Meta-analysis of chemotherapy regimens for ovarian carcinoma: a reassessment of cisplatin, cyclophosphamide and doxorubicin versus cisplatin and cyclophosphamide European Journal of Gynaecological Oncology 18(5): 343-348
Panova, I.E.; Vazhenin, A.V.; Usova, R.A.; Abunamus, S.M. 2004: Epidemiological aspects of basal cell cancer of the eyelids' skin in the Cheliabinsk region Vestnik Oftalmologii 120(2): 34-35
Logothetis, C.J.; Samuels, M.L.; Selig, D.E.; Wallace, S.; Johnson, D.E. 1985: Combined intravenous and intra-arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumors Cancer Treatment Reports 69(1): 33-38
Trifard, F.; Chrétien, Y.; Vallantin, X.; Collet, C.; Lachand, A.T.; Dufour, B. 1988: [Neoadjuvant chemotherapy (cisplatin, doxorubicin, cyclophosphamide) in the treatment of invasive urothelial tumors of the bladder. Preliminary results of a prospective study concerning 22 patients Annales d'Urologie 22(3): 216-219
Barker, G.H.; Wiltshaw, E. 1981: Randomised trial comparing low-dose cisplatin and chlorambucil with low-dose cisplatin, chlorambucil, and doxorubicin in advanced ovarian carcinoma Lancet 1(8223): 747-750
Stockfleth, E.; Ulrich, C.; Hauschild, A.; Lischner, S.; Meyer, T.; Christophers, E. 2002: Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod European Journal of Dermatology: Ejd 12(6): 569-572
Requena, L.; Fariña, M.C.; Robledo, M.; Sangueza, O.P.; Sanchez, E.; Villanueva, A.; Marquina, A.; Tamarit, R. 1999: Multiple hereditary infundibulocystic basal cell carcinomas: a genodermatosis different from nevoid basal cell carcinoma syndrome Archives of Dermatology 135(10): 1227-1235
Murata, K.; Shiraki, K.; Kawakita, T.; Yamamoto, N.; Okano, H.; Nakamura, M.; Sakai, T.; Deguchi, M.; Ohmori, S.; Nakano, T. 2003: Low-dose chemotherapy of cisplatin and 5-fluorouracil or doxorubicin via implanted fusion port for unresectable hepatocellular carcinoma Anticancer Research 23(2c): 1719-1722
Joss, R.A.; Alberto, P.; Obrecht, J.P.; Barrelet, L.; Holdener, E.E.; Siegenthaler, P.; Goldhirsch, A.; Mermillod, B.; Cavalli, F. 1984: Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide Cancer Treatment Reports 68(9): 1079-1084
Pasmantier, M.W.; Coleman, M.; Silver, R.T.; Ballard, W.P. 1985: Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens Cancer Treatment Reports 69(6): 689-693
Sukhaboon, J.; Porapakkhan, P.; Penpattanagul, S. 2009: Randomized comparison of fluorouracil plus cisplatin vs. cisplatin as an adjunct to radiation therapy in stage IIB-IVA squamous cell carcinoma of the cervix: pilot study Journal of the Medical Association of Thailand 92(8): 1072-1076
Goldberg, H.; Tsalik, M.; Bernstein, Z.; Haim, N. 1994: Cisplatin-based chemotherapy for advanced basal and squamous cell carcinomas Harefuah 127(7-8): 217
Salem, S.A.; Gamal Aly, D.; Salah Youssef, N.; Moneim El-Shaer, M.A. 2015: Immunohistochemical assessment of endothelin-1 axis in psoriasis, basal cell carcinoma and squamous cell carcinoma Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 150(3): 283-291
Bilgi, O.; Karagoz, B.; Alacacioglu, A.; Ozgun, A.; Tuncel, T.; Gokhan-Kandemir, E. 2010: Irinotecan and cisplatin vs. cyclophosphamide, doxorubicin, and vincristine as second-line treatment after platinum and etoposide in small-cell lung cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 15(2): 395
Wollina, U.; Schönlebe, J.; Tchernev, G.; Chokoeva, A.A.; Lotti, T. 2015: Basal cell carcinoma or not Basal cell carcinoma? That is the question! Journal of Biological Regulators and Homeostatic Agents 29(1 Suppl): 81-86
Takenouchi, T. 2008: Diagnosis and treatment for squamous cell carcinoma and basal cell carcinoma of skin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(4): 591-595
Breuninger, H.; Garbe, C. 1998: Squamous epithelial carcinoma of the skin including the lower lip and eyelids (spinalioma, spinous cell carcinoma). Quality Assurance Committee of the German Society of Dermatology and the Professional Organization of German Dermatologists e.V Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 48 Suppl. 1: S20-S26
Sorbe, B.; Hallén, C. 1991: Betamethasone-dixyrazine versus betamethasone-metoclopramide as antiemetic treatment of cisplatin-doxorubicin-induced nausea in ovarian carcinoma patients European Journal of Gynaecological Oncology 12(1): 31-37
Patel, M.; Sinha, A.A.; Gilbert, E. 2012: Bullous pemphigoid associated with renal cell carcinoma and invasive squamous cell carcinoma Journal of Drugs in Dermatology: Jdd 11(2): 234-238